drugset / Trial / NCT00398437

Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer

NCT00398437

Unknown 96 enrolled Jules Bordet Institute
RandomizedDiagnostic

Summary

RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI), may help doctors find CNS metastases and plan treatment. PURPOSE: This randomized clinical trial is studying how well MRI finds CNS metastases in women with stage IV breast cancer.

Timeline

Start
2006-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Trastuzumab Monoclonal antibody